Adicet Bio, Inc.
ACET- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720580
No open-market purchases or sales by Adicet Bio, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $52.8M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Adicet Bio, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 64 | 64 | 0 |
| Shares | 57.1M | 57.6M | +490.3K (+0.9%) |
| Value | $82.3M | $55.4M | −$26.8M (−32.6%) |
New holders (7)
Institutions that held Adicet Bio, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 968,183 | $931.4K | 0.09% |
| Squarepoint Ops LLC | 184,356 | $177.3K | 0.00% |
| Wealthedge Investment Advisors, LLC | 73,764 | $71.0K | 0.03% |
| Virtu Financial LLC | 30,611 | $29.0K | 0.00% |
| BNP Paribas Arbitrage, SA | 894 | $860 | 0.00% |
| SBI Securities Co., Ltd. | 171 | $165 | 0.00% |
| Royal Bank of Canada | 357 | $0 | 0.00% |
Sold out (7)
Institutions that held Adicet Bio, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Bank of Montreal | 78,704 | $112.5K |
| Two Sigma Securities, LLC | 23,296 | $33.5K |
| Graham Capital Management, L.P. | 21,496 | $31.0K |
| Cornercap Investment Counsel Inc | 18,074 | $26.0K |
| Catalyst Funds Management Pty Ltd | 13,700 | $19.7K |
| Bayesian Capital Management, LP | 12,621 | $18.2K |
| Northwest Financial Advisors | 1,685 | $2.43K |